---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-040179"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2026-04-06T23:59:59+00:00"
generated_at: "2026-05-15T07:24:01.378945+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Director Gaurav Aggarwal resigns from Unicycive board effective April 6

## Summary
- Gaurav Aggarwal resigned from the Board of Directors on April 6, 2026.
- Resignation was not due to any disagreement with the Company or management.
- Company expressed gratitude for Dr. Aggarwal's service on the Board.

## SEC filing metadata
- accession: 0001213900-26-040179
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2026-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390026040179/0001213900-26-040179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390026040179/ea0285174-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-040179
- JSON: https://secwatch.observer/filing/0001213900-26-040179.json
- Plain text: https://secwatch.observer/filing/0001213900-26-040179.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.